Ganciclovir and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported as a side effect among people who take Ganciclovir (ganciclovir), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Cytarabine, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Ganciclovir. It is created by eHealthMe based on reports of 6,363 people who have side effects when taking Ganciclovir from the FDA, and is updated regularly.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,290 drugs and 2,096 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

On Jul, 20, 2026

6,363 people reported to have side effects when taking Ganciclovir.
Among them, 12 people (0.19%) have Ventricular tachycardia.

Could Ganciclovir cause Ventricular tachycardia?

Among these 12 people:

How long have people been on Ganciclovir when they have Ventricular tachycardia? *

What is the gender of people who have Ventricular tachycardia when taking Ganciclovir? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Ventricular tachycardia when taking Ganciclovir? *

What are other drugs people take besides Ganciclovir? *

Methylprednisolone Sodium Succinate: 5 people, 41.67%
Acetaminophen: 5 people, 41.67%
Furosemide: 5 people, 41.67%
Cytarabine: 5 people, 41.67%
Voriconazole: 4 people, 33.33%
Acyclovir: 4 people, 33.33%
Lasix: 3 people, 25.00%
Ranitidine: 3 people, 25.00%
Morphine: 3 people, 25.00%
Methylprednisolone: 3 people, 25.00%

What are other side effects people have besides Ventricular tachycardia? *

Acute Kidney Failure: 4 people, 33.33%
Hypotension (abnormally low blood pressure): 3 people, 25.00%
Pulmonary Alveolar Haemorrhage (acute bleeding): 2 people, 16.67%
Insomnia (sleeplessness): 2 people, 16.67%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 2 people, 16.67%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 2 people, 16.67%
Cytomegalovirus Infection: 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Hepatic Failure (liver failure): 2 people, 16.67%
Oxygen Saturation Decreased: 2 people, 16.67%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 2 people, 16.67%
Neuralgia (pain in one or more nerves): 1 person, 8.33%
Lower Respiratory Tract Infection: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Cytomegalovirus Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ganciclovir and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ganciclovir:

Ganciclovir (6,370 reports)

Browse all side effects of Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular tachycardia:

Ventricular tachycardia (1,290 drugs)

Browse all the conditions that are associated with Ventricular tachycardia:

Ventricular tachycardia (2,096 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir (the active ingredients of Ganciclovir) and Ganciclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.